Bahman Amani

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Systematic Review

Extracorporeal Membrane Oxygenation

Coronavirus Disease

Top Venues

Journal of medical virology

British journal of clinical pharmacology

Scientific reports

Immunity, inflammation and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Behnam Amani, Bahman Amani
Azvudine versus Paxlovid in COVID-19: A systematic review and meta-analysis. Reviews in medical virology 34 (4) (2024)
Behnam Amani, Rouhollah Shabestan, Kourosh Rajabkhah, Bahman Amani
Sotrovimab in solid organ transplant recipients with COVID-19: a systematic review and meta-analysis. Korean journal of transplantation (2023)
Behnam Amani, Bahman Amani
Efficacy and safety of regdanvimab in patients with mild to moderate COVID-19: A rapid review and meta-analysis. British journal of clinical pharmacology (2023)
Behnam Amani, Bahman Amani
Efficacy and safety of regdanvimab in patients with mild to moderate COVID-19: A rapid review and meta-analysis. British journal of clinical pharmacology 89 (4) (2023)
Behnam Amani, Bahman Amani
Efficacy and safety of regdanvimab in patients with mild to moderate COVID-19: A rapid review and meta-analysis. British journal of clinical pharmacology (2023)
Bahman Amani, Arash Akbarzadeh, Behnam Amani, Rouhollah Shabestan, Saeed Khorramnia, Zia Navidi, Kourosh Rajabkhah, Vida Kardanmoghadam
Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID-19: A systematic review and meta-analysis. Journal of medical virology 95 (6) (2023)
Bahman Amani, Arash Akbarzadeh, Behnam Amani, Rouhollah Shabestan, Saeed Khorramnia, Zia Navidi, Kourosh Rajabkhah, Vida Kardanmoghadam
Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID-19: A systematic review and meta-analysis. Journal of medical virology 95 (6) (2023)
Behnam Amani, Bahman Amani
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis. Journal of medical virology 95 (2) (2023)
Behnam Amani, Bahman Amani
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis. Journal of medical virology 95 (2) (2023)
Behnam Amani, Bahman Amani
Efficacy and safety of regdanvimab in patients with mild to moderate COVID-19: A rapid review and meta-analysis. British journal of clinical pharmacology 89 (4) (2023)
Behnam Amani, Bahman Amani
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19 : a rapid review and meta-analysis. Journal of medical virology (2022)
Behnam Amani, Bahman Amani
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19 : a rapid review and meta-analysis. Journal of medical virology (2022)
Bahman Amani, Sara Zareei, Behnam Amani, Mahsa Zareei, Neda Zareei, Rouhollah Shabestan, Arash Akbarzadeh
Artesunate, imatinib, and infliximab in COVID-19: A rapid review and meta-analysis of current evidence. Immunity, inflammation and disease 10 (6) (2022)
Soheil Hassanipour, Morteza Arab-Zozani, Bahman Amani, Forough Heidarzad, Mohammad Fathalipour, Rudolph Martinez-de-Hoyo
Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials. Scientific reports 12 (1) (2022)
Behnam Amani, Bahman Amani
Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19 : a rapid review and meta-analysis. Journal of medical virology (2022)
Behnam Amani, Sara Zareei, Bahman Amani
Rapid review and meta-analysis of adverse events associated with molnupiravir in patients with COVID-19. British journal of clinical pharmacology 88 (10) (2022)
Behnam Amani, Bahman Amani, Sara Zareei, Mahsa Zareei
Efficacy and safety of arbidol (umifenovir) in patients with COVID-19: A systematic review and meta-analysis. Immunity, inflammation and disease 9 (4) (2021)
Soheil Hassanipour, Morteza Arab-Zozani, Bahman Amani, Forough Heidarzad, Mohammad Fathalipour, Rudolph Martinez-de-Hoyo
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials. Scientific reports 11 (1) (2021)